Status:
UNKNOWN
Multimodal MRI in Multiple Sclerosis (MS): Reliability and Follow Up
Lead Sponsor:
Groupe Hospitalier Pitie-Salpetriere
Collaborating Sponsors:
Institut National de la Santé Et de la Recherche Médicale, France
Conditions:
Multiple Sclerosis
Eligibility:
All Genders
18-50 years
Brief Summary
To determine wether multimodal MRI (conventinal T1 and T2 sequences, diffusion, magnetization transfer, spectroscopy) is reproducible; to follow up a cohort of patients with early remmittent MS after ...
Eligibility Criteria
Inclusion
- MS patients according to Poser's criteria
- Remitting evolution (less than two years of evolution)
- Aged 18-50
- Immunomodulatory treatment indicated
Exclusion
- Unable to perform MRI
Key Trial Info
Start Date :
Trial Type :
OBSERVATIONAL
End Date :
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT00289159
Last Update
February 9 2006
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.